LEADER 01259cam0-22004571i-450 001 990003361840403321 005 20220422104608.0 010 $a88-207-1340-3 035 $a000336184 035 $aFED01000336184 035 $a(Aleph)000336184FED01 035 $a000336184 100 $a20030910d1998----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $aDiritto del lavoro$fFabio Mazziotti 205 $a5. ed. 210 $aNapoli$cLiguori$d1998 215 $aX, 618 p.$d24 cm 225 1 $aManuali 610 0 $aDiritto del lavoro 676 $a344.4501 676 $a344 700 1$aMazziotti,$bFabio$0263256 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003361840403321 952 $aMAZ(5)344.4501B$b10019B$fDECBC 952 $aMAZ(5)344.4501C$b10019C$fDECBC 952 $aMAZ(5)344.4501A$b10019A$fDECBC 952 $aMAZ(6)344.4501D$b11693A$fDECBC 952 $aMAZ(6)344.4501F$b11693C$fDECBC 952 $aMAZ(6)344.4501E$b11693B$fDECBC 952 $aA-II-96$b8889 dip.$fDDRC 952 $aA-II-97$b8890 dip.$fDDRC 952 $aA-II-99$b9030 dip.$fDDRC 959 $aDECBC 959 $aDDRC 996 $aDiritto del lavoro$9196125 997 $aUNINA LEADER 04351nam 2200625 a 450 001 9910437855503321 005 20200520144314.0 010 $a1-283-69718-1 010 $a1-4614-4669-4 024 7 $a10.1007/978-1-4614-4669-9 035 $a(CKB)2670000000277596 035 $a(EBL)1030595 035 $a(OCoLC)813838372 035 $a(SSID)ssj0000767009 035 $a(PQKBManifestationID)11442121 035 $a(PQKBTitleCode)TC0000767009 035 $a(PQKBWorkID)10732098 035 $a(PQKB)11283721 035 $a(DE-He213)978-1-4614-4669-9 035 $a(MiAaPQ)EBC1030595 035 $a(PPN)168300885 035 $a(EXLCZ)992670000000277596 100 $a20121012d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEndoCANNABINOIDS $eactions at non-CB1/CB2 cannadinoid receptors /$fMary E. Abood, Roger G. Sorensen, Nephi Stella, editors 205 $a1st ed. 2013. 210 $aNew York $cSpringer$d2013 215 $a1 online resource (285 p.) 225 0 $aThe receptors 300 $aDescription based upon print version of record. 311 $a1-4899-8846-7 311 $a1-4614-4668-6 320 $aIncludes bibliographical references and index. 327 $aOverview of Non-Cannabinoid Receptors.Overview of Non-Classical Cannabinoid Receptors.Overview of Non-Cannabinoid Receptors: Chemistry and Modeling -- G-Protein Coupled Receptors.GPR55 in the CNS.The Role of GPR55 in Bone Biology.The Role of GPR55 in Cancer.GPR18 and NAGly signaling: New members of the endocannabinoid family or distant cousins?.Cannabinoid Signaling Through Non CB1/Non CB2 GPCR Targets in Microglia -- Ion Channels.Temperature-Sensitive Transient Receptor Potential Channels as Ionotropic Cannabinoid Receptors.Nonpsychoactive Cannabinoid Action on 5-HT3 and Glycine Receptors -- Transcription Factors.Peroxisome proliferator-activated receptors and inflammation.Peroxisome proliferator-activated nuclear receptors (PPAR) and drug addiction -- Conclusions/Therapeutic Potential.Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors. 330 $aThe cloning of two G protein-coupled cannabinoid receptors, termed CB1 and CB2, in the early 1990s has stimulated and facilitated research conducted on the physiological function of cannabinoid actions in the brain and throughout the body. In the twenty years since the identification of these two receptors, endogenous ligands (endocannabinoids) for these receptors have been identified, their biosynthetic and metabolic pathways have been discerned, and their functional and regulatory action for signalling through CB1 and CB2 receptors have been described. More recently, it has become has become evident that cannabinoids exert actions at non-CB1, non-CB2 receptors. Much less is understood about these actions. Many of these novel ?targets? are in the process of being characterized functionally and physiologically, and the therapeutic value of targeting these non-CB1, non-CB2 receptors is being evaluated. The purpose of this volume is to present the current knowledge on the atypical actions of cannabinoids on these new targets.   This book is intended as a scientific resource for cannabinoid researchers carrying out animal and human experiments, and for those who are interested in learning about future directions in cannabinoid research. Additionally, this book may be of value to investigators currently working outside the field of cannabinoid research who have an interest in learning about these compounds and their atypical cannabinoid signalling. This book provides insight into the potential medical application of cannabinoids and their therapeutic development for the treatment of human disease. 410 0$aThe Receptors,$x1048-6909 ;$v24 606 $aCannabinoids$xPhysiological effect 606 $aCannabinoids$xReceptors 615 0$aCannabinoids$xPhysiological effect. 615 0$aCannabinoids$xReceptors. 676 $a615.7827 701 $aAbood$b Mary E$01757216 701 $aSorensen$b Roger G$01757217 701 $aStella$b Nephi$01757218 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910437855503321 996 $aEndoCANNABINOIDS$94194989 997 $aUNINA